IP
ANIK icon

Indivisible Partners’s Anika Therapeutics ANIK Stock Holding History

Indivisible Partners’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$677K Sell
46,254
-3,503
-7% -$51.9K 0.04% 311
2026
Q1 		$721K Sell
49,757
-645
-1% -$7.49K 0.06% 224
2025
Q4 		$484K Buy
+50,402
New +$483K 0.05% 257

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return

Indivisible Partners's ANIK Position: Q2 2026 in Review

Indivisible Partners reduced its Anika Therapeutics (ANIK) stake by 7% in Q2 2026, selling an estimated $51.9K and leaving 46,254 shares worth $677K. The position accounts for 0.04% of the portfolio, ranked #311.

Indivisible Partners first reported a position in ANIK in Q4 2025 and has held it in 3 quarters since. The position peaked at $721K in Q1 2026. 133 funds tracked by Wall St. Rank hold ANIK as of Q2 2026.

  • Indivisible Partners held 46,254 shares of Anika Therapeutics worth $677K as of Q2 2026.
  • Indivisible Partners sold 3,503 Anika Therapeutics shares in Q2 2026, an estimated $51.9K.
  • Anika Therapeutics made up 0.04% of Indivisible Partners's portfolio in Q2 2026, its #311 holding.
  • Indivisible Partners first reported a position in Anika Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Indivisible Partners's Anika Therapeutics position peaked at $721K in Q1 2026.
  • 133 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2026.

Based on Indivisible Partners's 13F filing for Q2 2026, filed 4 Aug 2026.